Eli Lilly & Co. LLY
i
Market dataready · fetched 2026-11-07T01:12:57.102Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-13
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-07T00:58:26.224445622Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-07T01:12:56.483333+00:00
Eli Lilly & Co. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1406.50 | 29.4% | 4.1% | 1299.49 | 39.0% | 4.9% |
| 25Δ | 1400.15 | 31.7% | 3.8% | 1309.43 | 40.7% | 4.4% |
| 30Δ | 1391.54 | 32.2% | 3.4% | 1322.51 | 38.4% | 3.6% |
| 35Δ | 1382.85 | 32.1% | 2.9% | 1332.61 | 37.9% | 3.1% |
| 40Δ | 1374.66 | 31.9% | 2.5% | 1342.11 | 37.4% | 2.6% |
| 45Δ | 1366.68 | 31.1% | 2.1% | 1351.17 | 36.5% | 2.2% |
| 50Δ | 1359.34 | 32.2% | 1.9% | 1359.79 | 37.0% | 1.9% |
| 55Δ | 1351.57 | 33.5% | 1.7% | 1368.46 | 36.7% | 1.6% |
| 60Δ | 1343.57 | 33.5% | 1.4% | 1377.51 | 36.9% | 1.3% |
| 65Δ | 1335.00 | 34.1% | 1.2% | 1387.23 | 37.4% | 1.1% |
| 70Δ | 1325.16 | 35.4% | 1.0% | 1395.71 | 36.0% | 0.8% |
| 75Δ | 1315.95 | 34.9% | 0.8% | |||
| 80Δ | 1302.83 | 36.7% | 0.7% | |||
20Δ
- Pseudo strike
- 1406.50
- IV
- 29.4%
- B/E move
- 4.1%
- Pseudo strike
- 1299.49
- IV
- 39.0%
- B/E move
- 4.9%
25Δ
- Pseudo strike
- 1400.15
- IV
- 31.7%
- B/E move
- 3.8%
- Pseudo strike
- 1309.43
- IV
- 40.7%
- B/E move
- 4.4%
30Δ
- Pseudo strike
- 1391.54
- IV
- 32.2%
- B/E move
- 3.4%
- Pseudo strike
- 1322.51
- IV
- 38.4%
- B/E move
- 3.6%
35Δ
- Pseudo strike
- 1382.85
- IV
- 32.1%
- B/E move
- 2.9%
- Pseudo strike
- 1332.61
- IV
- 37.9%
- B/E move
- 3.1%
40Δ
- Pseudo strike
- 1374.66
- IV
- 31.9%
- B/E move
- 2.5%
- Pseudo strike
- 1342.11
- IV
- 37.4%
- B/E move
- 2.6%
45Δ
- Pseudo strike
- 1366.68
- IV
- 31.1%
- B/E move
- 2.1%
- Pseudo strike
- 1351.17
- IV
- 36.5%
- B/E move
- 2.2%
50Δ
- Pseudo strike
- 1359.34
- IV
- 32.2%
- B/E move
- 1.9%
- Pseudo strike
- 1359.79
- IV
- 37.0%
- B/E move
- 1.9%
55Δ
- Pseudo strike
- 1351.57
- IV
- 33.5%
- B/E move
- 1.7%
- Pseudo strike
- 1368.46
- IV
- 36.7%
- B/E move
- 1.6%
60Δ
- Pseudo strike
- 1343.57
- IV
- 33.5%
- B/E move
- 1.4%
- Pseudo strike
- 1377.51
- IV
- 36.9%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 1335.00
- IV
- 34.1%
- B/E move
- 1.2%
- Pseudo strike
- 1387.23
- IV
- 37.4%
- B/E move
- 1.1%
70Δ
- Pseudo strike
- 1325.16
- IV
- 35.4%
- B/E move
- 1.0%
- Pseudo strike
- 1395.71
- IV
- 36.0%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 1315.95
- IV
- 34.9%
- B/E move
- 0.8%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1302.83
- IV
- 36.7%
- B/E move
- 0.7%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 33.28% | |
| 32.79% | |
| 31.77% | |
| 31.56% | |
| 28.42% | |
| 31.68% | |
| 32.22% | |
| 32.97% | |
| 31.62% | |
| 30.79% | |
| 32.05% | |
| 32.81% | |
| 33.52% | |
| 32.18% | |
| 29.94% | |
| 31.47% | |
| 31.92% | |
| 31.63% | |
| 31.10% | |
| 30.11% | |
| 34.53% | |
| 33.13% | |
| 33.38% | |
| 30.65% | |
| 32.63% | |
| 33.84% | |
| 33.96% | |
| 32.53% | |
| 30.52% | |
| 32.75% | |
| 32.24% | |
| 32.32% | |
| 32.87% | |
| 31.28% | |
| 33.68% | |
| 33.14% | |
| 33.87% | |
| 32.41% | |
| 32.51% | |
| 34.67% | |
| 35.55% | |
| 35.75% | |
| 36.26% | |
| 36.61% | |
| 39.33% | |
| 40.42% | |
| 42.16% | |
| 41.14% | |
| 42.35% | |
| 44.09% | |
| 45.80% | |
| 45.67% | |
| 47.45% | |
| 47.95% | |
| 54.27% | |
| 58.61% | |
| 62.46% | |
| 37.43% | |
| 34.19% |
Drug Manufacturers - General
MRK
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in…
More →NVO
Novo Nordisk A / S, a healthcare company, is dedicated to the research, development, manufacture and marketing of pharmaceutical products globally. The company is headquartered in…
More →NVS
Novartis AG researches, develops, manufactures and markets medical devices worldwide. The company is headquartered in Basel, Switzerland.
More →OGN
Organon & Co. is an American pharmaceutical company headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine,…
More →PFE
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company…
More →SNY
Description unavailable
More →